Amedeo Smart

Free Medical Literature Service



Autoimmune Disorders

  Free Subscription

Articles published in
J Neuroimmunol
    October 2022
  1. BEECHER G, Howe BM, Shelly S, Staff NP, et al
    Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMN.
    J Neuroimmunol. 2022;371:577953.
    >> Share

  2. FEIZI P, Sharma K, Pasham SR, Nirwan L, et al
    Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
    J Neuroimmunol. 2022;371:577939.
    >> Share

    September 2022
  3. LAMBE J, McGinley MP, Moss BP, Mao-Draayer Y, et al
    Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.
    J Neuroimmunol. 2022;370:577933.
    >> Share

  4. KASHYAP N, Morris M, Loerinc LB, Benoit M, et al
    The neutrophil-to-lymphocyte ratio is associated with intubation in pediatric anti-NMDA receptor encephalitis: A retrospective study.
    J Neuroimmunol. 2022;370:577931.
    >> Share

  5. KELLY H, Johnson J, Jakubecz C, Serra A, et al
    Prevalence of iatrogenic CNS inflammation at a tertiary neuroimmunology clinic.
    J Neuroimmunol. 2022;370:577928.
    >> Share

  6. HARAMATI A, Rechtman A, Zveik O, Haham N, et al
    IL-6 as a marker for NMOSD disease activity.
    J Neuroimmunol. 2022;370:577925.
    >> Share

  7. MAGALASHVILI D, Mandel M, Dreyer-Alster S, Didikin M, et al
    Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
    J Neuroimmunol. 2022;372:577966.
    >> Share

    August 2022
  8. WU H, Chen L, Zhou X, Wu Y, et al
    Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
    J Neuroimmunol. 2022;372:577955.
    >> Share

  9. ORTIGOZA-ESCOBAR JD, Fernandez de Sevilla M, Monfort L, Anton J, et al
    Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant.
    J Neuroimmunol. 2022;369:577917.
    >> Share

  10. JIANG W, Sun X, Huang H, Sun H, et al
    Bilateral parafalcine cortical and leptomeningeal impairment in MOG antibody disease and AQP4 neuromyelitis optica.
    J Neuroimmunol. 2022;369:577898.
    >> Share

  11. NEWSOME SD, Johnson T
    Stiff person syndrome spectrum disorders; more than meets the eye.
    J Neuroimmunol. 2022;369:577915.
    >> Share

    Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.
    J Neuroimmunol. 2022;369:577901.
    >> Share

  13. CAO B, Luo M, Li J, Lu Y, et al
    Cerebrospinal fluid cystatin C levels in patients with anti-NMDAR encephalitis and other neurological diseases.
    J Neuroimmunol. 2022;369:577900.
    >> Share

  14. RACKE MK, Batish SD, Lisak RP, Barohn RJ, et al
    LRP4 antibody testing in myasthenia gravis.
    J Neuroimmunol. 2022;371:577949.
    >> Share

  15. ISHIZUCHI K, Takizawa T, Ohnuki Y, Sekiguchi K, et al
    Immunodeficiency in patients with thymoma-associated myasthenia gravis.
    J Neuroimmunol. 2022;371:577950.
    >> Share

    July 2022
  16. ALOISI F, Cross AH
    MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.
    J Neuroimmunol. 2022;371:577935.
    >> Share

  17. FUCHS L, Mausner-Fainberg K, Luban A, Asseyer SE, et al
    CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
    J Neuroimmunol. 2022;371:577936.
    >> Share

  18. MURAKAMI K, Miyamoto K, Terayama A, Yoshikawa K, et al
    Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.
    J Neuroimmunol. 2022;368:577880.
    >> Share

  19. DAS NEVES SP, Serre-Miranda C, Sousa JC, Costa PS, et al
    Lipocalin-2 does not influence EAE clinical score but it increases inflammation in central nervous system.
    J Neuroimmunol. 2022;368:577872.
    >> Share

  20. VAN DER WEELE L, Pollastro S, van Schaik BDC, van Kampen AHC, et al
    Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif) using B cell receptor repertoire analysis.
    J Neuroimmunol. 2022;370:577932.
    >> Share

  21. FONAGER SV, Winther G, Wittenborn TR, Jensen L, et al
    Increased maternofoetal transfer of antibodies in a murine model of systemic lupus erythematosus, but no immune activation and neuroimmune sequelae in offspring.
    J Neuroimmunol. 2022;370:577927.
    >> Share

  22. KASHEKE GDS, Holman SP, Robertson GS
    Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;370:577926.
    >> Share

  23. STRIJBOS E, van Ostaijen-Ten Dam MM, Vervat C, Schilham MW, et al
    The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis.
    J Neuroimmunol. 2022;370:577930.
    >> Share

    June 2022
  24. WEIHUA Z, Haitao R, Jie D, Changhong R, et al
    Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
    J Neuroimmunol. 2022;370:577918.
    >> Share

  25. RACKE MK, Niles JK, Lorenz RA, Kaufman HW, et al
    Changes in ganglioside antibody positivity rates during the COVID-19 pandemic.
    J Neuroimmunol. 2022;367:577877.
    >> Share

  26. NIE DA, Abud A, Serrano-Gonzalez M, Harappanahally G, et al
    Pediatric stiff limb syndrome with polyautoimmunity of anti-GAD-65, anti-islet cell, and thyroid peroxidase antibodies: A case report and review of literature.
    J Neuroimmunol. 2022;367:577865.
    >> Share

  27. MASI G, Li Y, Karatz T, Pham MC, et al
    The clinical need for clustered AChR cell-based assay testing of seronegative MG.
    J Neuroimmunol. 2022;367:577850.
    >> Share

  28. HU K, Yang Y, Liu J, Chen X, et al
    Susac syndrome with the typical clinical triad: A case report and literature review.
    J Neuroimmunol. 2022;367:577822.
    >> Share

  29. YAO Y, Zhang O, Gu L, Zhang X, et al
    Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis.
    J Neuroimmunol. 2022;369:577899.
    >> Share

  30. CHAN F, Riminton DS, Ramanathan S, Reddel SW, et al
    Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to "overlap" cases.
    J Neuroimmunol. 2022;369:577904.
    >> Share

    May 2022
  31. YAO Y, Uddin MN, Manley K, Lawrence DA, et al
    Improvements of autism-like behaviors but limited effects on immune cell metabolism after mitochondrial replacement in BTBR T(+)Itpr3(tf)/J mice.
    J Neuroimmunol. 2022;368:577893.
    >> Share

  32. KLEIN CJ, Beecher G, Lamb C, Naddaf E, et al
    LRP4-IgG service line testing in seronegative myasthenia gravis and controls.
    J Neuroimmunol. 2022;368:577895.
    >> Share

  33. PAUL SA, Roy D, Mondal GP, Bhattacharyya R, et al
    Primary angiitis of central nervous system - A challenging diagnosis.
    J Neuroimmunol. 2022;366:577844.
    >> Share

  34. DINOTO A, McKeon A, Vattemi G, Carta S, et al
    Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma.
    J Neuroimmunol. 2022;368:577882.
    >> Share

  35. GILL AJ, Venkatesan A
    Pathogenic mechanisms in neuronal surface autoantibody-mediated encephalitis.
    J Neuroimmunol. 2022;368:577867.
    >> Share

    April 2022
  36. WANG J, Jin L, Zhang X, Yu H, et al
    Activated microglia by (18)F-DPA714 PET in a case of anti-LGI1 autoimmune encephalitis.
    J Neuroimmunol. 2022;368:577879.
    >> Share

  37. FERILLI MAN, Papi C, Sabatelli M, Colosimo C, et al
    MOG autoimmunity mimicking CLIPPERS syndrome: Case report and literature review.
    J Neuroimmunol. 2022;367:577875.
    >> Share

  38. MA R, Chu Y, Dou M, Jing Y, et al
    Matrine inhibits the Wnt3a/beta-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;367:577876.
    >> Share

  39. KYLLESBECH C, Trier N, Slibinskas R, Ciplys E, et al
    Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis.
    J Neuroimmunol. 2022;367:577868.
    >> Share

  40. ODA F, Uzawa A, Ozawa Y, Yasuda M, et al
    Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.
    J Neuroimmunol. 2022;365:577833.
    >> Share

  41. DEKEYSER C, Naesens L, Offner F, De Vriendt C, et al
    A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome.
    J Neuroimmunol. 2022;367:577866.
    >> Share

  42. MCKEON-MAKKI I, McKeon A, Yang B, Pittock SJ, et al
    Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients.
    J Neuroimmunol. 2022;367:577861.
    >> Share

    March 2022
  43. JIN J, Shneyderman M, Smith MD, Gharagozloo M, et al
    Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice.
    J Neuroimmunol. 2022;367:577859.
    >> Share

  44. TOTTENHAM I, Koch M, Camara-Lemarroy C
    Serum HGF and APN2 are associated with disability worsening in SPMS.
    J Neuroimmunol. 2022;364:577803.
    >> Share

  45. NEPAL G, Kharel S, Coghlan MA, Rayamajhi P, et al
    Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis.
    J Neuroimmunol. 2022;364:577812.
    >> Share

  46. WENG J, Du Z, Zhang Y
    CNS limited ANCA-associated vasculitis presenting as an isolated intraparenchymal mass.
    J Neuroimmunol. 2022;364:577791.
    >> Share

  47. DIAZ P, Leveque M, Hautecloque G, Sellal F, et al
    The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
    J Neuroimmunol. 2022;366:577842.
    >> Share

  48. SALARI AA, Jand Y, Ghazi-Khansari M
    Antibiotic treatment during pregnancy and lactation in dams exacerbates clinical symptoms and inflammatory responses in offspring with experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;366:577840.
    >> Share

    February 2022
  49. MA J, Yu H, Wang H, Zhang X, et al
    Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    J Neuroimmunol. 2022;363:577790.
    >> Share

  50. COSTA D, Sardoeira A, Carneiro P, Neves E, et al
    Autoimmune encephalitis: suspicion in clinical practice and mimics.
    J Neuroimmunol. 2022;365:577824.
    >> Share

    January 2022
  51. MOLLER L, Kerwat M, Timmermann L, Simon OJ, et al
    When your cat takes you to the ICU: Miller Fisher/ Guillain-Barre-overlap-syndrome caused by Pasteurella multocida infection resembling wound botulism.
    J Neuroimmunol. 2022;365:577821.
    >> Share

  52. ISMAIL II, Salama S
    A systematic review of cases of CNS demyelination following COVID-19 vaccination.
    J Neuroimmunol. 2022;362:577765.
    >> Share

  53. MA X, Chen C, Fang L, Zhong X, et al
    Dysregulated CD40 and CD40 ligand expression in anti-N-methyl-d-aspartate receptor encephalitis.
    J Neuroimmunol. 2022;362:577762.
    >> Share

  54. KADISH R, Clardy SL, Royston M, Tanvir I, et al
    Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis.
    J Neuroimmunol. 2022;362:577761.
    >> Share

  55. KALININ S, Boullerne AI, Feinstein DL
    Serum levels of lipocalin-2 are elevated at early times in African American relapsing remitting multiple sclerosis patients.
    J Neuroimmunol. 2022;364:577810.
    >> Share

  56. YE F, Dai Y, Wang T, Liang J, et al
    Trans-omics analyses revealed key epigenetic genes associated with overall survival in secondary progressive multiple sclerosis.
    J Neuroimmunol. 2022;364:577809.
    >> Share

  57. BRORSON IS, Eriksson AM, Hogestol E, Leikfoss IS, et al
    Global DNA methylation changes in treated and untreated MS patients measured over time.
    J Neuroimmunol. 2022;364:577808.
    >> Share

  58. URRIOLA N, Blazek K, Adelstein S
    Subunit-specific autoantibodies in autoimmune autonomic ganglionopathy.
    J Neuroimmunol. 2022;363:577805.
    >> Share

    December 2021
  59. RONCHI NR, Silva GD
    Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic review.
    J Neuroimmunol. 2021;363:577804.
    >> Share

  60. DIAS DA COSTA M, Leal Rato M, Cruz D, Valadas A, et al
    Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection.
    J Neuroimmunol. 2021;361:577739.
    >> Share

  61. THOLANCE Y, Antoine JC, Mohr L, Jung M, et al
    Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern.
    J Neuroimmunol. 2021;361:577757.
    >> Share

  62. TALBOT J, Hojsgaard Chow H, Holm Hansen R, von Essen MR, et al
    Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS.
    J Neuroimmunol. 2021;361:577756.
    >> Share

  63. REN H, Fan S, Zhao Y, Guan H, et al
    The changing spectrum of antibody-mediated encephalitis in China.
    J Neuroimmunol. 2021;361:577753.
    >> Share

  64. PUJARI SS, Kulkarni RV, Ojha P, Gursahani R, et al
    Acute haemorrhagic leukoencephalitis (AHLE) - our experience and a short review.
    J Neuroimmunol. 2021;361:577751.
    >> Share

  65. DIAS L, Barbosa L, Martins F, Braz L, et al
    Risk factors for idiopathic myelitis at admission and predictors for late diagnostic change.
    J Neuroimmunol. 2021;361:577747.
    >> Share

  66. SAHA S, Mukherjee S, Guha G, Mukhopadhyay D, et al
    Dynamics of AQP4 upon exposure to seropositive patient serum before and after Rituximab therapy in Neuromyelitis Optica: A cell-based study.
    J Neuroimmunol. 2021;361:577752.
    >> Share

  67. NAGIREDDY RBR, Kumar A, Singh VK, Prasad R, et al
    Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    J Neuroimmunol. 2021;361:577742.
    >> Share

  68. KESHVARI MK, van Someren F, Sheikh S, Galea I, et al
    Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns.
    J Neuroimmunol. 2021;361:577729.
    >> Share

  69. STECK AJ
    Anti-MAG neuropathy: From biology to clinical management.
    J Neuroimmunol. 2021;361:577725.
    >> Share

  70. ADAMEC I, Rogic D, Penz MG, Braun C, et al
    Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab.
    J Neuroimmunol. 2021;362:577788.
    >> Share

  71. SONG J, Yang J, Jing S, Yan C, et al
    Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets.
    J Neuroimmunol. 2021;362:577787.
    >> Share

  72. TOLJAN K, Amin M, Kunchok A, Ontaneda D, et al
    New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure.
    J Neuroimmunol. 2021;362:577785.
    >> Share

    November 2021
  73. CHEN B, Tian DS, Bu BT
    Immunological predictors for the outcome in patients with antibody-mediated autoimmune encephalitis.
    J Neuroimmunol. 2021;362:577779.
    >> Share

    Comments on "Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine" by , J Neuroimmunol.
    J Neuroimmunol. 2021;362:577780.
    >> Share

  75. WUERCH E, Mishra M, Melo H, Ebacher V, et al
    Quantitative analysis of spinal cord neuropathology in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;362:577777.
    >> Share

  76. JIAO L, Li H, Guo S
    Eculizumab treatment for myasthenia gravis subgroups: 2021 update.
    J Neuroimmunol. 2021;362:577767.
    >> Share

  77. HWANG D, Boehm A, Rostami A, Zhang GX, et al
    Oral D-mannose treatment suppresses experimental autoimmune encephalomyelitis via induction of regulatory T cells.
    J Neuroimmunol. 2021;362:577778.
    >> Share

  78. HASSANSHAHI G, Noroozi Karimabad M, Jebali A
    The therapeutic effect of PEGlated nanoliposome of pistachio unsaturated oils and its efficacy to attenuate inflammation in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial phase I.
    J Neuroimmunol. 2021;362:577768.
    >> Share

    SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy.
    J Neuroimmunol. 2021;360:577703.
    >> Share

  80. POURMOGHADDAS Z, Sadeghizadeh A, Tara SZ, Zandifar A, et al
    Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report.
    J Neuroimmunol. 2021;360:577704.
    >> Share

  81. MOLAZADEH N, Filippatou AG, Vasileiou ES, Levy M, et al
    Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2021;360:577702.
    >> Share

  82. FREEDMAN MS, Wojcik J, Holmberg KH, Fluck M, et al
    Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION.
    J Neuroimmunol. 2021;360:577715.
    >> Share

  83. NILLES C, Poillon G, Deschamps L, Daval M, et al
    IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case report.
    J Neuroimmunol. 2021;360:577717.
    >> Share

  84. PANDIT L, Malli C, D'Cunha A, Sudhir A, et al
    Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost effective cell based assay.
    J Neuroimmunol. 2021;360:577706.
    >> Share

  85. PACHE F, Ringelstein M, Aktas O, Kleiter I, et al
    C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
    J Neuroimmunol. 2021;360:577699.
    >> Share

  86. MASCIA E, Clarelli F, Zauli A, Guaschino C, et al
    Burden of rare coding variants in an Italian cohort of familial multiple sclerosis.
    J Neuroimmunol. 2021;362:577760.
    >> Share

    October 2021
  87. VAKRAKOU AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, et al
    IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients.
    J Neuroimmunol. 2021;361:577759.
    >> Share

  88. FUJIMORI J, Miyazawa K, Nakashima I
    Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
    J Neuroimmunol. 2021;361:577755.
    >> Share

  89. ZELADA-RIOS L, Pacheco-Barrios K, Galecio-Castillo M, Yamunaque-Chunga C, et al
    Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases.
    J Neuroimmunol. 2021;359:577674.
    >> Share

  90. SRIWASTAVA S, Lisak RP
    Acetylcholine receptor antibodies in a patient with sensory neuropathy.
    J Neuroimmunol. 2021;359:577692.
    >> Share

  91. TANG H, Wang L, Zhou H, Hao X, et al
    Psychiatric symptoms as initial manifestation in neuromyelitis optica spectrum disorder without cortical lesions: A report of two cases.
    J Neuroimmunol. 2021;359:577693.
    >> Share

  92. GOI LDS, Altenhofen S, Nabinger DD, Bonan CD, et al
    Decreased convulsive threshold and memory loss after anti-NMDAR positive CSF injection in zebrafish.
    J Neuroimmunol. 2021;359:577689.
    >> Share

  93. OTA S, Kotani T, Matsuda S, Nishioka D, et al
    Initial serum GM-CSF levels are associated with the severity of cerebral small vessel disease in microscopic polyangiitis patients.
    J Neuroimmunol. 2021;359:577671.
    >> Share

  94. SANTIAGO JA, Babico M, Stitt G, Thomas CA, et al
    Low-dose intrathecal rituximab is a safe and potentially effective treatment for pediatric neuroimmunologic disorders.
    J Neuroimmunol. 2021;359:577687.
    >> Share

  95. ACHIRON A, Mandel M, Dreyer-Alster S, Harari G, et al
    Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
    J Neuroimmunol. 2021;361:577746.
    >> Share

  96. KIMURA A, Kato S, Takekoshi A, Yoshikura N, et al
    Autoimmune glial fibrillary acidic protein astrocytopathy resembling isolated central nervous system lymphomatoid granulomatosis.
    J Neuroimmunol. 2021;361:577748.
    >> Share

  97. CHE NN, Chen SY, Li X, Ma JJ, et al
    Autoimmune-mediated secondary-parkinsonism presented with micrographia and cognitive impairment.
    J Neuroimmunol. 2021;361:577738.
    >> Share

  98. SEGAL JP, Phillips S, Dubois RM, Silva JR, et al
    Weight bearing as a measure of disease progression in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;361:577730.
    >> Share

    September 2021
  99. OO WM, Giri P, de Souza A
    AstraZeneca COVID-19 vaccine and Guillain- Barre Syndrome in Tasmania: A causal link?
    J Neuroimmunol. 2021;360:577719.
    >> Share

    Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations.
    J Neuroimmunol. 2021;358:577660.
    >> Share

  101. GHOSH R, Dubey S, Mandal A, Ray BK, et al
    Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.
    J Neuroimmunol. 2021;358:577655.
    >> Share

  102. PAGENKOPF C, Sudmeyer M
    A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
    J Neuroimmunol. 2021;358:577606.
    >> Share

  103. SRIWASTAVA S, Kataria S, Srivastava S, Kazemlou S, et al
    Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis.
    J Neuroimmunol. 2021;360:577721.
    >> Share

  104. VAN LIEVERLOO GGA, Wieske L, van Schaik IN, Deijs M, et al
    Virus discovery in chronic inflammatory demyelinating polyneuropathy.
    J Neuroimmunol. 2021;358:577668.
    >> Share

  105. MORCH MT, Khorooshi R, Marczynska J, Dubik M, et al
    Mitochondria-A target for attenuation of astrocyte pathology.
    J Neuroimmunol. 2021;358:577657.
    >> Share

  106. SECHI E, Zarbo R, Biancu MA, Chessa P, et al
    Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2021;358:577666.
    >> Share

  107. ZHAO X, Yang P
    Hydroxychloroquine alleviates the neurotoxicity induced by anti-ribosomal P antibodies.
    J Neuroimmunol. 2021;358:577648.
    >> Share

  108. BAEK SH, Kim B, Shin JY, Choi SJ, et al
    EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
    J Neuroimmunol. 2021;358:577637.
    >> Share

  109. GOMBOLAY GY, Gadde JA
    Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review.
    J Neuroimmunol. 2021;358:577653.
    >> Share

  110. XIAO J, Chen X, Shang K, Tang Y, et al
    Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retrospective study.
    J Neuroimmunol. 2021;360:577718.
    >> Share

  111. PHILLIPS O, Tubre T, Lorenco H, Batish SD, et al
    Limbic encephalitis in a child with ovarian teratoma and influenza B. Case report and critical review of the history of autoimmune anti-N-methyl-d-aspartate receptor encephalitis.
    J Neuroimmunol. 2021;360:577716.
    >> Share

    August 2021
  112. HAYASHI F, Isobe N, Cossu D, Yokoyama K, et al
    Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis.
    J Neuroimmunol. 2021;360:577701.
    >> Share

  113. FARSHBAFNADI M, Agah E, Rezaei N
    The second brain: The connection between gut microbiota composition and multiple sclerosis.
    J Neuroimmunol. 2021;360:577700.
    >> Share

  114. RIBES GARCIA S, Casanova Estruch B, Gomez Pajares F, Juan Blanco MA, et al
    Prognostic utility of the IgM oligoclonal bands against myelin lipids in multiple sclerosis.
    J Neuroimmunol. 2021;359:577698.
    >> Share

  115. BRAINER-LIMA JPM, Leite BHS, de Araujo CMCS, Dhalia R, et al
    Are Zika virus cross-reactive antibodies against aquaporin-4 associated to Neuromyelitis Optica Spectrum Disorder?
    J Neuroimmunol. 2021;360:577697.
    >> Share

  116. HABEK M, Jakob Brecl G, Basic Kes V, Rogic D, et al
    Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.
    J Neuroimmunol. 2021;359:577696.
    >> Share

  117. QIAO X, Wang H, Lu L, Chen J, et al
    Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice.
    J Neuroimmunol. 2021;357:577620.
    >> Share

  118. CHAKRABORTY AP, Pandit A, Ray BK, Mukherjee A, et al
    Capgras syndrome and confabulation unfurling anti NMDAR encephalitis with classical papillary thyroid carcinoma: First reported case.
    J Neuroimmunol. 2021;357:577611.
    >> Share

  119. EQUIZA J, Rodriguez-Antiguedad J, Campo-Caballero D, Iruzubieta P, et al
    Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises.
    J Neuroimmunol. 2021;359:577695.
    >> Share

  120. COSSU D, Yokoyama K, Sato S, Noda S, et al
    PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE).
    J Neuroimmunol. 2021;359:577694.
    >> Share

  121. MIN YG, Ju W, Ha YE, Ban JJ, et al
    Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
    J Neuroimmunol. 2021;359:577691.
    >> Share

  122. HAHAM N, Vaknin-Dembinsky A
    COVID-19 in Cladribine-treated patient with multiple sclerosis.
    J Neuroimmunol. 2021;359:577690.
    >> Share

    July 2021
  123. KRAUS EE, Kakuk-Atkins L, Farinas MF, Jeffers M, et al
    Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity.
    J Neuroimmunol. 2021;359:577675.
    >> Share

  124. LOVETT-RACKE AE, Yang Y, Liu Y, Gormley M, et al
    B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
    J Neuroimmunol. 2021;359:577676.
    >> Share

  125. LAI QL, Cai MT, Zheng Y, Zhang TY, et al
    Seasonal variation in autoimmune encephalitis: A multi-center retrospective study.
    J Neuroimmunol. 2021;359:577673.
    >> Share

  126. YAO Y, Li X, Lin J, Zhang X, et al
    Thymoma-associated autoimmune encephalitis with positive Titin antibodies: A case report.
    J Neuroimmunol. 2021;358:577670.
    >> Share

  127. GUO L, Ren H, Fan S, Guan H, et al
    Autoantibody against the Rab6A/Rab6B in primary autoimmune cerebellar ataxia associated with Sjogren's syndrome: A case report.
    J Neuroimmunol. 2021;359:577667.
    >> Share

  128. WANG J, Yan C, Zhao Z, Chen H, et al
    Sexual dysfunction in patients with myasthenia gravis.
    J Neuroimmunol. 2021;358:577669.
    >> Share

  129. CAPARO-ZAMALLOA C, Alvarez-Toledo K, Yamunaque-Chunga C, Castro-Suarez S, et al
    Autoimmune neurology: Co-occurrence of anti-NMDAR encephalitis and anti-MOG associated disease, report of a case.
    J Neuroimmunol. 2021;358:577663.
    >> Share

  130. LOCKHART A, Boers P
    Paraneoplastic neurologic syndromes with multiple neural autoantibodies: A report of two cases.
    J Neuroimmunol. 2021;358:577665.
    >> Share

  131. LI R, Wang J, Li C, Liu X, et al
    Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
    J Neuroimmunol. 2021;356:577604.
    >> Share

  132. DINOTO A, Cheli M, Bratina A, Sartori A, et al
    Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review.
    J Neuroimmunol. 2021;356:577586.
    >> Share

  133. NARESH K, Miraclin TA, Prabhakar AT, Mathew V, et al
    Epstein-Barr virus infection in a woman with aquaporin-4 seropositive neuromyelitis optica.
    J Neuroimmunol. 2021;356:577581.
    >> Share

  134. WONG CK, Hor JY, Loo YP, Heng HS, et al
    High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, Malaysia.
    J Neuroimmunol. 2021;356:577584.
    >> Share

  135. HONGO Y, Kaida K, Komuta Y, Takazaki H, et al
    Cholesterol-added antigens can enhance antiglycolipid antibody activity: Application to antibody testing.
    J Neuroimmunol. 2021;356:577580.
    >> Share

  136. NISHRI Y, Fainstein N, Goldfarb S, Hampton D, et al
    Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse.
    J Neuroimmunol. 2021;356:577582.
    >> Share

  137. MIMPEN M, Damoiseaux J, van Doorn W, Rolf L, et al
    Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients.
    J Neuroimmunol. 2021;358:577664.
    >> Share

  138. CORTES-VICENTE E, Alvarez-Velasco R, Illa I, Gallardo E, et al
    Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis".
    J Neuroimmunol. 2021;358:577659.
    >> Share

  139. IVANOVA M, Voronkova A, Sukhorukov V, Zakharova M, et al
    Different neuroinflammatory gene expression profiles in highly active and benign multiple sclerosis.
    J Neuroimmunol. 2021;358:577650.
    >> Share

  140. KHANMOHAMMADI S, Malekpour M, Jabbari P, Rezaei N, et al
    Genetic basis of Guillain-Barre syndrome.
    J Neuroimmunol. 2021;358:577651.
    >> Share

    June 2021
  141. MOSTAFA GA, Meguid NA, Shehab AAS, Elsaeid A, et al
    Plasma levels of nerve growth factor in Egyptian autistic children: Relation to hyperserotonemia and autoimmunity.
    J Neuroimmunol. 2021;358:577638.
    >> Share

  142. MIRZAEI R, Zamani F, Hajibaba M, Rasouli-Saravani A, et al
    The pathogenic, therapeutic and diagnostic role of exosomal microrna in the autoimmune diseases.
    J Neuroimmunol. 2021;358:577640.
    >> Share

  143. JAKHMOLA S, Upadhyay A, Jain K, Mishra A, et al
    Herpesviruses and the hidden links to Multiple Sclerosis neuropathology.
    J Neuroimmunol. 2021;358:577636.
    >> Share

  144. UZAWA A, Akamine H, Kojima Y, Ozawa Y, et al
    High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
    J Neuroimmunol. 2021;358:577634.
    >> Share

    Steroid-responsive, transverse myelitis is a known complication of COVID-19.
    J Neuroimmunol. 2021;355:577566.
    >> Share

  146. LEE JK, Kwon S, Han JH, Yoon SE, et al
    Increased proportion of CD20+ T cells after rituximab treatment in patient with neuromyelitis optica later diagnosed with lung B-cell lymphoma: A case report.
    J Neuroimmunol. 2021;355:577564.
    >> Share

  147. GOVIL-DALELA T, Datta I, Williams M
    Refractory NMDA-receptor encephalitis in a teenager: A novel use of Bortezomib.
    J Neuroimmunol. 2021;355:577565.
    >> Share

  148. SON H, Lee WJ, Moon J, Yoon S, et al
    Isolated CNS involvement in eosinophilic granulomatosis with polyangiitis treated with mepolizumab: A case report.
    J Neuroimmunol. 2021;355:577551.
    >> Share

  149. REYES S, Cunningham AL, Kalincik T, Havrdova EK, et al
    Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.
    J Neuroimmunol. 2021;357:577627.
    >> Share

  150. FINSTERER J, Ghosh R
    Dimensions of SARS-CoV-2 associated Guillain-Barre syndrome.
    J Neuroimmunol. 2021;357:577626.
    >> Share

  151. NIINO M, Fukazawa T, Miyazaki Y, Ura S, et al
    Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.
    J Neuroimmunol. 2021;357:577624.
    >> Share

    May 2021
  152. GRISANTI SG, Franciotta D, Garnero M, Zuppa A, et al
    A case series of parainfectious Guillain-Barre syndrome linked to influenza A (H1N1) virus infection.
    J Neuroimmunol. 2021;357:577605.
    >> Share

  153. MANOUCHEHRI N, Guisso DR, Hussain RZ, Minassian BA, et al
    The antioxidant MnTBAP does not effectively downregulate CD4 expression in T cells in vivo.
    J Neuroimmunol. 2021;354:577544.
    >> Share

  154. WANG T, Wang B, Zeng Z, Li H, et al
    Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study.
    J Neuroimmunol. 2021;354:577527.
    >> Share

  155. FINSTERER J, Scorza FA, Scorza CA, Fiorini AC, et al
    Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.
    J Neuroimmunol. 2021;357:577609.
    >> Share

  156. SVIRIDOVA A, Rogovskii V, Kudrin V, Pashenkov M, et al
    The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis.
    J Neuroimmunol. 2021;356:577608.
    >> Share

  157. ROTOLO RA, Demuro J, Drummond G, Little C, et al
    Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;356:577603.
    >> Share

  158. SOLTANMORADI S, Tavakolpour V, Moghadasi AN, Kouhkan F, et al
    Expression analysis of NF-kappaB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients.
    J Neuroimmunol. 2021;356:577602.
    >> Share

  159. KELLY H, Sokola B, Abboud H
    Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients.
    J Neuroimmunol. 2021;356:577599.
    >> Share

  160. ZULIANI L, Marangoni S, De Gaspari P, Rosellini I, et al
    Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics.
    J Neuroimmunol. 2021 May 1:577598. doi: 10.1016/j.jneuroim.2021.577598.
    >> Share

    April 2021
  161. YOKOTE H
    Author's response in reply to "Question about data: Importance of serum amyloid A level in patients with multiple sclerosis".
    J Neuroimmunol. 2021;356:577589.
    >> Share

  162. DOPPLER K, Hemprich A, Haarmann A, Brecht I, et al
    Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis.
    J Neuroimmunol. 2021;356:577588.
    >> Share

  163. GARCIA-MANTEIGA JM, Clarelli F, Bonfiglio S, Mascia E, et al
    Identification of differential DNA methylation associated with multiple sclerosis: A family-based study.
    J Neuroimmunol. 2021;356:577600.
    >> Share

  164. MASI G, Spagni G, Campetella L, Monte G, et al
    Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis.
    J Neuroimmunol. 2021;356:577601.
    >> Share

  165. PAPRI N, Hayat S, Mohammed A, Afsar MNA, et al
    Guillain-Barre syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
    J Neuroimmunol. 2021;356:577590.
    >> Share

  166. HOU H, Sun Y, Miao J, Gao M, et al
    Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;356:577583.
    >> Share

  167. SHEIKH AB, Chourasia PK, Javed N, Chourasia MK, et al
    Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review.
    J Neuroimmunol. 2021;355:577577.
    >> Share

  168. MORENO-ESCOBAR MC, Kataria S, Khan E, Subedi R, et al
    Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
    J Neuroimmunol. 2021;353:577523.
    >> Share

  169. JUMAH M, Rahman F, Figgie M, Prasad A, et al
    COVID-19, HHV6 and MOG antibody: A perfect storm.
    J Neuroimmunol. 2021;353:577521.
    >> Share

  170. WANG J, Qiu Z, Li D, Dong H, et al
    Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
    J Neuroimmunol. 2021;353:577515.
    >> Share

  171. ZHANG H, Yang Y, Luo X
    Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report.
    J Neuroimmunol. 2021;353:577519.
    >> Share

  172. LI C, Wang J, Sun X, Li R, et al
    The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China.
    J Neuroimmunol. 2021;353:577506.
    >> Share

  173. DIEM L, Hoepner R, Bagnoud M, Salmen A, et al
    Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature.
    J Neuroimmunol. 2021;353:577505.
    >> Share

  174. FANG F, Wang Y, Xu W
    Anti-N-methyl-d-aspartate receptor encephalitis associated with intracranial cryptococcal infection: A case report and 2-year follow-up.
    J Neuroimmunol. 2021;353:577502.
    >> Share

  175. DU Q, Shi Z, Chen H, Zhang Y, et al
    Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2021;353:577494.
    >> Share

  176. PRADO MB JR, Narito KM, Adiao KJB
    Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever.
    J Neuroimmunol. 2021;355:577572.
    >> Share

  177. FAN Z, Zheng D, Wen X, Shen F, et al
    CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients.
    J Neuroimmunol. 2021;355:577571.
    >> Share

  178. DINIZ SN, da Silva CF, de Almeida IT, da Silva Costa FE, et al
    INFbeta treatment affects global DNA methylation in monocytes of patients with multiple sclerosis.
    J Neuroimmunol. 2021;355:577563.
    >> Share

    March 2021
  179. GUEDES BF, Ribeiro AF, Pinto LF, Vidal JE, et al
    Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases.
    J Neuroimmunol. 2021;355:577548.
    >> Share

  180. LAZAREVIC M, Djedovic N, Stanisavljevic S, Dimitrijevic M, et al
    Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies.
    J Neuroimmunol. 2021;354:577547.
    >> Share

  181. DINOTO A, Bosco A, Sartori A, Bratina A, et al
    Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies.
    J Neuroimmunol. 2021;352:577488.
    >> Share

  182. LI X, Hou C, Wu WL, Liang H, et al
    Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.
    J Neuroimmunol. 2021;352:577479.
    >> Share

  183. DAY GS, Gordon BA, Bucelli RC, Perrin RJ, et al
    Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient.
    J Neuroimmunol. 2021;352:577474.
    >> Share

  184. COSSU D, Yokoyama K, Sakanishi T, Kuwahara-Arai K, et al
    A mucosal immune response induced by oral administration of heat-killed Mycobacterium avium subsp. paratuberculosis exacerbates EAE.
    J Neuroimmunol. 2021;352:577477.
    >> Share

  185. CHAUDHARY P, Marracci GH, Calkins E, Pocius E, et al
    Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.
    J Neuroimmunol. 2021;352:577468.
    >> Share

  186. GIARRAPUTO J, Giamberardino S, Arvai S, Maichle S, et al
    Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis.
    J Neuroimmunol. 2021;354:577541.
    >> Share

    February 2021
  187. XIANG W, Xie C, Guan Y
    The identification, development and therapeutic potential of IL-10-producing regulatory B cells in multiple sclerosis.
    J Neuroimmunol. 2021;354:577520.
    >> Share

  188. LI H, Huang Z, Jia D, Xue H, et al
    Low-dose rituximab treatment for new-onset generalized myasthenia gravis.
    J Neuroimmunol. 2021;354:577528.
    >> Share

  189. LUCCHINI M, Giuffre GM, Nociti V, Bianco A, et al
    Defining the disease course of TNFalpha blockers-associated Multiple Sclerosis.
    J Neuroimmunol. 2021;353:577525.
    >> Share

  190. AKAISHI T, Misu T, Takahashi T, Takai Y, et al
    Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders.
    J Neuroimmunol. 2021;351:577467.
    >> Share

  191. CHOUDHARY A, Bhargava A, Khichar S, Pradhan S, et al
    Etiological spectrum, clinico-radiological profile and treatment outcomes of longitudinally extensive transverse myelitis - A prospective study from Northwest India.
    J Neuroimmunol. 2021;351:577456.
    >> Share

  192. THIRUNAVUKKARASU B, Gupta K, Nada R, Rathi M, et al
    Neuropathological spectrum in systemic lupus erythematosus: A single institute autopsy experience.
    J Neuroimmunol. 2021;353:577518.
    >> Share

  193. UCHIDA N, Mori K, Fujita-Nakata M, Nakanishi M, et al
    Systemic cellular immunity and neuroinflammation during acute flare-up in multiple sclerosis and neuromyelitis optica spectrum disorder patients.
    J Neuroimmunol. 2021;353:577500.
    >> Share

  194. LI Q, Liu Y, Zeng Y
    Questions about data: Importance of serum amyloid A level in patients with multiple sclerosis.
    J Neuroimmunol. 2021;353:577516.
    >> Share

    January 2021
  195. YUE YX, Gao X, Tang TP, Xie Y, et al
    Complement C3 polymorphism is associated with the susceptibility of myasthenia gravis in Chinese adult patients.
    J Neuroimmunol. 2021;353:577487.
    >> Share

  196. BEER R, Lehn A, Blum S
    A case of Anti-LGi-1 antibody positive autoimmune epilepsy following deep brain stimulator implantation for essential tremor.
    J Neuroimmunol. 2021;353:577503.
    >> Share

  197. NING P, Yang B, Yang X, Huang H, et al
    Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barre syndrome.
    J Neuroimmunol. 2021;353:577504.
    >> Share

  198. KHADEMI B, Khorrami M, Ayromlou H, Rikhtegar R, et al
    An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis.
    J Neuroimmunol. 2021;353:577507.
    >> Share

  199. BROADLEY J, Wesselingh R, Seneviratne U, Kyndt C, et al
    Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis.
    J Neuroimmunol. 2021;353:577508.
    >> Share

  200. MIMPEN M, Rolf L, Muris AH, Gerlach O, et al
    NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.
    J Neuroimmunol. 2021;353:577499.
    >> Share

  201. ONMAZ DE, Isik SMT, Abusoglu S, Ekmekci AH, et al
    Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis.
    J Neuroimmunol. 2021;353:577497.
    >> Share

  202. NIU Y, Li Y
    The serum alpha-synuclein levels in patients with multiple sclerosis need more evidence.
    J Neuroimmunol. 2021;352:577465.
    >> Share

  203. MORIGUCHI K, Miyamoto K, Fukumoto Y, Kusunoki S, et al
    Change in light-dark cycle affects experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;353:577495.
    >> Share

  204. CHU Y, Jing Y, Zhao X, Wang M, et al
    Modulation of the HMGB1/TLR4/NF-kappaB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2021;352:577480.
    >> Share

  205. ZILIOTTO N, Lamberti N, Manfredini F, Straudi S, et al
    Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients.
    J Neuroimmunol. 2021;352:577473.
    >> Share

    December 2020
  206. KOHLE F, Sprenger A, Klein I, Fink GR, et al
    Nerve conductions studies in experimental models of autoimmune neuritis: A meta-analysis and guideline.
    J Neuroimmunol. 2020;352:577470.
    >> Share

  207. STASCHEIT F, Li L, Mai K, Baum K, et al
    Delayed onset hypophysitis after therapy with daclizumab for multiple sclerosis - A report of two cases.
    J Neuroimmunol. 2020;351:577469.
    >> Share

  208. YOKOTE H, Toru S, Nishida Y, Hattori T, et al
    Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis.
    J Neuroimmunol. 2020;351:577466.
    >> Share

  209. AKAISHI T, Fujimori J, Takahashi T, Misu T, et al
    Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody.
    J Neuroimmunol. 2020;349:577431.
    >> Share

  210. UZAWA A, Ozawa Y, Yasuda M, Kuwabara S, et al
    Severe worsening of myasthenic symptoms after the eculizumab discontinuation.
    J Neuroimmunol. 2020;349:577424.
    >> Share

  211. GARCIA-FERNANDEZ FJ, Garcia-Fernandez AE, Nava E, Del Pozo JSG, et al
    A bibliometric evaluation of the top 100 cited natalizumab articles.
    J Neuroimmunol. 2020;349:577379.
    >> Share

  212. HUSSEIN O, Abd Elazim A, Torbey MT
    Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM).
    J Neuroimmunol. 2020;349:577405.
    >> Share

  213. ZHENG Y, Luo J, Jin H, Gao F, et al
    Cerebrospinal fluid CD20 positive B-cell expansion in a case of anti-NMDAR encephalitis.
    J Neuroimmunol. 2020;349:577365.
    >> Share

    November 2020
  214. MOUTRAN-BARROSO H, Kreinter-Rosembaun H, Beltran S MA, Bayona H, et al
    The multiple faces of encephalitis: Antibody profile in a case series of autoimmune encephalitis in Bogota, Colombia.
    J Neuroimmunol. 2020;350:577451.
    >> Share

  215. MA X, Kermode AG, Hu X, Qiu W, et al
    NMOSD acute attack: Understanding, treatment and innovative treatment prospect.
    J Neuroimmunol. 2020;348:577387.
    >> Share

  216. GHOSH R, Dubey S, Ray BK, Purkait S, et al
    Isolated opsoclonus heralding neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2020;348:577394.
    >> Share

  217. XING X, Li J, Chen S, Zheng L, et al
    Anti-CASPR2 antibody associated encephalitis with anosmia and demyelinating pseudotumor: A case report.
    J Neuroimmunol. 2020;348:577393.
    >> Share

  218. KWON YN, Kim B, Ahn S, Seo J, et al
    Serum level of IL-1beta in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD).
    J Neuroimmunol. 2020;348:577361.
    >> Share

  219. GUO J, Han B, Wang J, Zhang L, et al
    The differential expression and potential roles of circular RNAs in children with anti-NMDA receptor encephalitis.
    J Neuroimmunol. 2020;348:577381.
    >> Share

  220. BILGE N, Simsek F, Yevgi R, Ceylan M, et al
    Low serum Alpha-SYNUCLEIN and oligomer Alpha-SYNUCLEIN levels in multiple sclerosis patients.
    J Neuroimmunol. 2020;350:577432.
    >> Share

  221. MONTEIRO A, Rosado P, Rosado L, Fonseca AM, et al
    Alterations in peripheral blood monocyte and dendritic cell subset homeostasis in relapsing-remitting multiple sclerosis patients.
    J Neuroimmunol. 2020;350:577433.
    >> Share

  222. GONCALVES MVM, Brandao WN, Longo C, Peron JPS, et al
    Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS).
    J Neuroimmunol. 2020;350:577435.
    >> Share

    October 2020
  223. SUN H, Wang J, Guo L, Wang Y, et al
    The combined treatment of NAD(+) and atorvastatin ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    J Neuroimmunol. 2020;350:577429.
    >> Share

  224. MARTINEZ-LARROSA J, Matute-Blanch C, Montalban X, Comabella M, et al
    Modelling multiple sclerosis using induced pluripotent stem cells.
    J Neuroimmunol. 2020;349:577425.
    >> Share

  225. JEBALI A, Noroozi Karimabad M, Ahmadi Z, Khorramdel H, et al
    Attenuation of inflammatory response in the EAE model by PEGlated nanoliposome of pistachio oils.
    J Neuroimmunol. 2020;347:577352.
    >> Share

  226. QIU Y, Zhou Q, Du Q, Chen H, et al
    Seasonal variation in relapse of neuromyelitis optica spectrum disorders: A retrospective study in China.
    J Neuroimmunol. 2020;347:577351.
    >> Share

  227. DUBEY S, Ghosh R, Dubey MJ, Sengupta S, et al
    Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psychotic disorder.
    J Neuroimmunol. 2020;347:577329.
    >> Share

  228. LI HX, Zuo L, Peng XX, Zong Q, et al
    Immunoglobulin G4-related hypertrophic pachymeningitis with spinal cord compression: A case report.
    J Neuroimmunol. 2020;347:577325.
    >> Share

    September 2020
  229. MATTEO G, Massimiliano T, Giorgia C, Silvia S, et al
    AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus.
    J Neuroimmunol. 2020;349:577407.
    >> Share

  230. NEKRASOVA I, Shirshev S
    Estriol in regulation of cell-mediated immune reactions in multiple sclerosis.
    J Neuroimmunol. 2020;349:577421.
    >> Share

  231. HAWKE S, Zinger A, Juillard PG, Holdaway K, et al
    Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment.
    J Neuroimmunol. 2020;349:577392.
    >> Share

  232. YAN C, Zhao R, Song J, Feng X, et al
    Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
    J Neuroimmunol. 2020;349:577403.
    >> Share

  233. YAMAKAWA M, Mukaino A, Kimura A, Nagasako Y, et al
    Antibodies to the alpha3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis.
    J Neuroimmunol. 2020;349:577399.
    >> Share

  234. YILMAZ V, Tuzun E, Durmus H, Oflazer P, et al
    The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients.
    J Neuroimmunol. 2020;349:577402.
    >> Share

  235. HOWLETT-PRIETO Q, Langer C, Rezania K, Soliven B, et al
    Modulation of immune responses by bile acid receptor agonists in myasthenia gravis.
    J Neuroimmunol. 2020;349:577397.
    >> Share

  236. ZHONG H, Lu J, Jing S, Xi J, et al
    Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients.
    J Neuroimmunol. 2020;348:577383.
    >> Share

  237. PARKHOUSE RME, Sciutto E, Hernandez M, Cortez MM, et al
    Extraparenchymal human neurocysticercosis induces autoantibodies against brain tubulin and MOG35-55 in cerebral spinal fluid.
    J Neuroimmunol. 2020;349:577389.
    >> Share

  238. DAS A, Khurshid S, Hayat S, Ahmed R, et al
    Glucocorticoid receptor gene polymorphisms in Guillain-Barre syndrome.
    J Neuroimmunol. 2020;348:577388.
    >> Share

  239. SIGNORIELLO E, Iardino P, Casertano S, De Lucia D, et al
    12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
    J Neuroimmunol. 2020;348:577385.
    >> Share

  240. ZOUVELOU V, Psimenou E
    AChR-and MuSK-positive myasthenia gravis: Double trouble.
    J Neuroimmunol. 2020;348:577364.
    >> Share

    August 2020
  241. ZHAN L, Fan M, Cai N, Cai B, et al
    Combination of autoimmune pancreatitis and peripheral neuropathy on an IgG4-related disease patient with 4 years following-up.
    J Neuroimmunol. 2020;348:577378.
    >> Share

  242. HEBERT J, Gros P, Lapointe S, Amtashar FS, et al
    Searching for autoimmune encephalitis: Beware of normal CSF.
    J Neuroimmunol. 2020;345:577285.
    >> Share

  243. LI X, Gao Q, Yang L, Han M, et al
    Matairesinol ameliorates experimental autoimmune uveitis by suppression of IRBP-specific Th17 cells.
    J Neuroimmunol. 2020;345:577286.
    >> Share

  244. JIAO L, Xiang Y, Li S, Zhang F, et al
    Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155.
    J Neuroimmunol. 2020;345:577280.
    >> Share

  245. ISMAIL S, Engin K, Ozan K, Mustafa C, et al
    Analysis of plasma protein biomarkers in childhood onset multiple sclerosis.
    J Neuroimmunol. 2020;348:577359.
    >> Share

  246. TRENOVA AG, Miteva LD, Stanilova SA
    Association between TNFA, IL10 and IL18 promoter gene variants and cognitive functions in patients with relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2020;347:577357.
    >> Share

  247. SOTIROPOULOS MG, Chitnis T
    Opposing and potentially antagonistic effects of BMP and TGF-beta in multiple sclerosis: The "Yin and Yang" of neuro-immune Signaling.
    J Neuroimmunol. 2020;347:577358.
    >> Share

  248. IBRAHIM SH, El-Mehdawy KM, Seleem M, El-Sawalhi MM, et al
    Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression.
    J Neuroimmunol. 2020;347:577356.
    >> Share

  249. SALAVISA M, Paixao P, Ladeira AF, Mendes A, et al
    Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse.
    J Neuroimmunol. 2020;347:577355.
    >> Share

    July 2020
  250. GARG D, Agarwal A, Bhagyawant R, Sikand TS, et al
    De novo nose-pinching stereotypy with somnolence: Clues to autoimmune encephalitis.
    J Neuroimmunol. 2020;347:577348.
    >> Share

  251. ACAR NP, Tuncer A, Ozkazanc D, Ozbay FG, et al
    An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta1 and fingolimod therapy.
    J Neuroimmunol. 2020;347:577353.
    >> Share

  252. GHADERIAN S, Shomali N, Behravesh S, Danbaran GR, et al
    The emerging role of lncRNAs in multiple sclerosis.
    J Neuroimmunol. 2020;347:577347.
    >> Share

  253. STEFANOVIC M, Zivotic I, Stojkovic L, Dincic E, et al
    The association of genetic variants IL2RA rs2104286, IFI30 rs11554159 and IKZF3 rs12946510 with multiple sclerosis onset and severity in patients from Serbia.
    J Neuroimmunol. 2020;347:577346.
    >> Share

  254. CULLER G, Bachman E, VanHaerents S
    Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis.
    J Neuroimmunol. 2020;347:577324.
    >> Share

  255. CIARDI MR, Zingaropoli MA, Pasculli P, Perri V, et al
    The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia.
    J Neuroimmunol. 2020;346:577323.
    >> Share

  256. KENNEDY PGE, Graner MW, Walker D, Pointon T, et al
    Recombinant antibodies derived from laser captured single plasma cells of multiple sclerosis brain identified phage peptides which may be used as tools for characterizing intrathecal IgG response.
    J Neuroimmunol. 2020;347:577319.
    >> Share

  257. TIAN X, Chen C, Ma L, Wei R, et al
    Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
    J Neuroimmunol. 2020;347:577317.
    >> Share

  258. HOUEN G, Heiden J, Trier NH, Draborg AH, et al
    Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis.
    J Neuroimmunol. 2020;346:577314.
    >> Share

  259. KEYVANI H, Zahednasab H, Aljanabi HAA, Asadi M, et al
    The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis.
    J Neuroimmunol. 2020;346:577313.
    >> Share

    June 2020
  260. YETKIN MF, Mirza M
    Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patients.
    J Neuroimmunol. 2020;346:577307.
    >> Share

  261. FARAHMAND F, Nourshahi M, Soleimani M, Rajabi H, et al
    The effect of 6 weeks of high intensity interval training on myelin biomarkers and demyelination in experimental autoimmune encephalomyelitis model.
    J Neuroimmunol. 2020;346:577306.
    >> Share

  262. FARZI MA, Ayromlou H, Jahanbakhsh N, Bavil PH, et al
    Guillain-Barre syndrome in a patient infected with SARS-CoV-2, a case report.
    J Neuroimmunol. 2020;346:577294.
    >> Share

  263. AL-NASERI MAS, Salman ED, Ad'hiah AH
    Relapsing-remitting multiple sclerosis: A profile of interleukine-1 gene cluster polymorphisms in Iraqi patients.
    J Neuroimmunol. 2020;346:577291.
    >> Share

  264. RYBERG B, Arvidsson A, Bergkvist M, Nilsson P, et al
    Limbic encephalitis in a neuroscientist: CASPR 2 antibody-associated disease after antigen exposure.
    J Neuroimmunol. 2020;343:577231.
    >> Share

  265. JUNG KO, Moon HJ
    A case of NMDAR encephalitis treated in the third trimester - novel arterial spin labeling findings and a review of literature.
    J Neuroimmunol. 2020;343:577235.
    >> Share

  266. AKAISHI T, Takahashi T, Fujihara K, Misu T, et al
    Risk factors of attacks in neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2020;343:577236.
    >> Share

  267. GONZALEZ-ALVARADO MN, Rotger C, Berger L, London B, et al
    Functional role of endogenous Kv1.4 in experimental demyelination.
    J Neuroimmunol. 2020;343:577227.
    >> Share

  268. NAJJAR E, Staun-Ram E, Volkowich A, Miller A, et al
    Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS.
    J Neuroimmunol. 2020;343:577230.
    >> Share

  269. SUN H, Ma X, Sun X, Wu L, et al
    Is transient hyperCKemia a new feature of neuromyelitis optica spectrum disorders? A retrospective study in 439 patients.
    J Neuroimmunol. 2020;343:577228.
    >> Share

  270. AHARONI R, Eilam R, Schottlender N, Radomir L, et al
    Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
    J Neuroimmunol. 2020;345:577281.
    >> Share

    May 2020
  271. RACKE MK, Newsome SD
    Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration.
    J Neuroimmunol. 2020 May 31:577283. doi: 10.1016/j.jneuroim.2020.577283.
    >> Share

  272. CHIARINI M, Paghera S, Moratto D, Rossi N, et al
    Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
    J Neuroimmunol. 2020;345:577282.
    >> Share

  273. LI Y, Guptill JT, Russo MA, Howard JF Jr, et al
    Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.
    J Neuroimmunol. 2020;345:577279.
    >> Share

  274. GRIFFITH SP, Malpas CB, Alpitsis R, O'Brien TJ, et al
    The neuropsychological spectrum of anti-LGI1 antibody mediated autoimmune encephalitis.
    J Neuroimmunol. 2020;345:577271.
    >> Share

  275. MAURICE C, Khoja L, Morgan E, Mason WP, et al
    Guillain-Barre Syndrome following a series of novel therapies adapting the gold-standard in the era of immune priming.
    J Neuroimmunol. 2020;346:577267.
    >> Share

  276. KAPADIA RK, Ney DE, Hannan M, Farley M, et al
    Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.
    J Neuroimmunol. 2020;344:577259.
    >> Share

    April 2020
  277. KEFALOPOULOU ZM, Liossis SN, Sagona T, Veltsista D, et al
    An ischemic stroke as the presenting manifestation of rapidly progressive primary angiitis of central nervous system in a 17-year-old boy.
    J Neuroimmunol. 2020;341:577190.
    >> Share

  278. LI X, Guo Q, Zheng Z, Wang X, et al
    Immune-mediated epilepsy with GAD65 antibodies.
    J Neuroimmunol. 2020;341:577189.
    >> Share

  279. BERNARDO F, Rebordao L, Rego A, Machado S, et al
    Stiff person spectrum disorders: An illustrative case series of their phenotypic and antibody diversity.
    J Neuroimmunol. 2020;341:577192.
    >> Share

  280. SHIBUYA K, Tsuneyama A, Misawa S, Sekiguchi Y, et al
    Different distribution of demyelination in chronic inflammatory demyelinating polyneuropathy subtypes.
    J Neuroimmunol. 2020;341:577170.
    >> Share

  281. PREVEZIANOU A, Tzartos JS, Dagklis IE, Bentenidi E, et al
    Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase-related protein VIII autoantibodies.
    J Neuroimmunol. 2020;344:577242.
    >> Share

  282. ANEJA J, Kuppili PP, Paul K, Panda S, et al
    Antiphospholipid syndrome presenting as treatment resistant bipolar disorder and thrombocytopenia in a young male.
    J Neuroimmunol. 2020;343:577238.
    >> Share

  283. BOULLERNE AI, Adami GR, Schwartz JL, Skias D, et al
    Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity.
    J Neuroimmunol. 2020;343:577237.
    >> Share

  284. PARKHOUSE RME, Carpio A, Cortez MM, von Kriegsheim A, et al
    Anti-brain protein autoantibodies are detectable in extraparenchymal but not parenchymal neurocysticercosis.
    J Neuroimmunol. 2020;344:577234.
    >> Share

    March 2020
  285. PRABHAT N, Chakravarty K, Pattnaik SN, Takkar A, et al
    Systemic lupus erythematosus with autoimmune neurological manifestations in a carrier of chronic granulomatous disease - a rare presentation.
    J Neuroimmunol. 2020;343:577229.
    >> Share

  286. MUKE I, Sprenger A, Bobylev I, Wiemer V, et al
    Ultrastructural characterization of mitochondrial damage in experimental autoimmune neuritis.
    J Neuroimmunol. 2020;343:577218.
    >> Share

  287. BOLDRINI VO, Brandao CO, Pimentel MLV, Vidal A, et al
    Massive activity of cytotoxic cells during refractory Neuromyelitis Optica spectrum disorder.
    J Neuroimmunol. 2020;340:577148.
    >> Share

  288. AKAISHI T, Takahashi T, Himori N, Fujihara K, et al
    Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2020;340:577168.
    >> Share

  289. URIBE-SAN-MARTIN R, Ciampi E, Cruz JP, Vasquez M, et al
    Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate.
    J Neuroimmunol. 2020;340:577144.
    >> Share

  290. MADDISON P, Gozzard P, Sadalage G, Ambrose PA, et al
    Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
    J Neuroimmunol. 2020;340:577149.
    >> Share

  291. PEDAPATI R, Bhatia R, Singh N, Bali P, et al
    Anti-myelin oligodendrocyte glycoprotein antibody associated disease spectrum - A north Indian tertiary care centre experience and review of literature.
    J Neuroimmunol. 2020;340:577143.
    >> Share

    February 2020
  292. OGATA H, Isobe N, Zhang X, Yamasaki R, et al
    Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy.
    J Neuroimmunol. 2020;339:577139.
    >> Share

  293. SHI Z, Qiu Y, Wang J, Fang Y, et al
    Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
    J Neuroimmunol. 2020;339:577126.
    >> Share

  294. BRILL L, Vaknin-Dembinsky A, Zveik O, Haham N, et al
    MIF -173G/C polymorphism is associated with NMO disease severity.
    J Neuroimmunol. 2020;339:577120.
    >> Share

  295. GARIMELLA V, McVoy JS, Oh U
    The contribution of cyclophilin A to immune-mediated central nervous system inflammation.
    J Neuroimmunol. 2020;339:577118.
    >> Share

  296. ZHANG W, Dong M, Dong H, Wang W, et al
    Reduced sarcolemmal aquaporin 4 expression can support the differential diagnosis of neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2020;339:577121.
    >> Share

  297. GOMES NA, Silva PC, Teixeira YT, Eufrazio P, et al
    HLA-G Ins/Del polymorphism and +3142C/G SNP are not related to neuromyelitis optica spectrum disorder (NMOSD) development, disability status or anti-aquaporin 4 presence in Brazilian patients.
    J Neuroimmunol. 2020;339:577112.
    >> Share

  298. NYSTAD AE, Lereim RR, Wergeland S, Oveland E, et al
    Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
    J Neuroimmunol. 2020;339:577091.
    >> Share

    January 2020
  299. ZHANG Y, Zhang Q, Shi Z, Chen H, et al
    Sexual dysfunction in patients with neuromyelitis optica spectrum disorder.
    J Neuroimmunol. 2020;338:577093.
    >> Share

  300. AGASING AM, Gawde S, Kumar G, Turner E, et al
    B cell function impacts the efficacy of IFN-beta therapy in EAE.
    J Neuroimmunol. 2020;338:577106.
    >> Share

  301. BLACKBURN K, Wang C, Greenberg B
    Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma.
    J Neuroimmunol. 2020;338:577092.
    >> Share

    July 2019
  302. NICOLETTI F, Mazzon E, Fagone P, Mangano K, et al
    Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.
    J Neuroimmunol. 2019;332:224-232.
    >> Share

  303. DZANGUE-TCHOUPOU G, Allenbach Y, Preusse C, Stenzel W, et al
    Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome.
    J Neuroimmunol. 2019;332:212-215.
    >> Share

  304. JAZEBI N, Rodrigo S, Gogia B, Shawagfeh A, et al
    Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
    J Neuroimmunol. 2019;332:135-137.
    >> Share

  305. ENRIQUEZ CAG, Espiritu AI, Pasco PMD
    Efficacy and tolerability of mitoxantrone for neuromyelitis optica spectrum disorder: A systematic review.
    J Neuroimmunol. 2019;332:126-134.
    >> Share

  306. NEEDHAM EJ, Helmy A, Zanier ER, Jones JL, et al
    The immunological response to traumatic brain injury.
    J Neuroimmunol. 2019;332:112-125.
    >> Share

  307. FREUND B, Ritzl EK
    A review of EEG in anti-NMDA receptor encephalitis.
    J Neuroimmunol. 2019;332:64-68.
    >> Share

  308. CAVALIERE E, Nosadini M, Pelizza MF, Ventura G, et al
    Anti-NMDAR encephalitis preceded by non-herpetic central nervous system infection: Systematic literature review and first case of tick-borne encephalitis triggering anti-NMDAR encephalitis.
    J Neuroimmunol. 2019;332:1-7.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016